Garrison Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Garrison Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,298	Closed	-$212K	–	98
2019 Q4	$212K	Buy	+3,298	New	+$189K	0.1%	106
2018 Q4	–	Sell	-3,342	Closed	-$207K	–	102
2018 Q3	$207K	Buy	+3,342	New	+$198K	0.1%	104
2017 Q1	–	Sell	-3,654	Closed	-$214K	–	102
2016 Q4	$214K	Buy	+3,654	New	+$200K	0.13%	96

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Garrison Asset Management's BMY Position: Q1 2020 in Review

Garrison Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,298 shares — an estimated $212K sold.

Garrison Asset Management first reported a position in BMY in Q4 2016 and held it in 3 quarters. The position peaked at $214K in Q4 2016. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

Garrison Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
Garrison Asset Management sold 3,298 Bristol-Myers Squibb shares in Q1 2020, an estimated $212K.
Garrison Asset Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 3 quarters.
Garrison Asset Management's Bristol-Myers Squibb position peaked at $214K in Q4 2016.
2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Garrison Asset Management's 13F filing for Q1 2020, filed 4 May 2020.